G
GSK plc
Period
FY 2025
Revenue
—
Net Income
$6.29B
Total Assets
$61.12B
Equity
—
Shares Out
4.32B
Op. Cash Flow
—
Business
GSK plc is a foreign private issuer in Pharmaceutical Preparations, headquartered in the United Kingdom. Shares trade over-the-counter under the ticker GLAXF.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $6.29B |
| Total assets | $61.12B |
| Total liabilities | $45.16B |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Holdings (13F)
Portfolio as of 2026-03-31 · 13 positions
Reported AUM
$599.15M
Holdings
13
Top sector
$599.15M
Top sectors
| Sector | Value | % of portfolio |
|---|---|---|
| Uncategorized | $599.15M | 100.0% |
Top holdings
| Issuer | Ticker | Shares | Value | % |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | — | 3.22M | $153.21M | 25.6% |
| WAVE LIFE SCIENCES LTD | — | 18.25M | $132.28M | 22.1% |
| BIONTECH SE | — | 889.8K | $79.09M | 13.2% |
| VIR BIOTECHNOLOGY INC | — | 8.55M | $76.62M | 12.8% |
| IDEAYA BIOSCIENCES INC | — | 1.33M | $44.43M | 7.4% |
| LYELL IMMUNOPHARMA INC | — | 1.51M | $30.34M | 5.1% |
| CYTOKINETICS INC | — | 340.4K | $22.44M | 3.7% |
| SPERO THERAPEUTICS INC | — | 9.19M | $21.51M | 3.6% |
| FULCRUM THERAPEUTICS INC | — | 1.79M | $13.70M | 2.3% |
| CVRX INC | — | 1.01M | $9.53M | 1.6% |
Frequently asked questions
What is GSK plc's CIK number?
GSK plc's SEC CIK number is 0001131399 (1131399). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find GSK plc's SEC filings?
All of GSK plc's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.